Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 16:05 ET | Source: OPKO Health, Inc.

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2025. Highlights from the first...
April 17, 2025 08:00 ET | Source: OPKO Health, Inc.

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025

MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2025 after the close of the U.S....
April 04, 2025 08:00 ET | Source: OPKO Health, Inc.

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common...
March 17, 2025 08:00 ET | Source: OPKO Health, Inc.

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement...
February 27, 2025 16:10 ET | Source: OPKO Health, Inc.

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

MIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the...
February 13, 2025 16:05 ET | Source: OPKO Health, Inc.

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2024 after the close of the...
January 09, 2025 11:45 ET | Source: OPKO Health, Inc.

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 43rd Annual J.P. Morgan Healthcare Conference, being held...
January 07, 2025 08:00 ET | Source: OPKO Health, Inc.

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with several types of cancer and multiple sclerosisThere are no current treatments or vaccines for EBVFirst participant dosed...
November 20, 2024 08:00 ET | Source: OPKO Health, Inc.

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

MIAMI, Nov. 20, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 36th Annual Healthcare Conference, being held...
November 07, 2024 16:05 ET | Source: OPKO Health, Inc.

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

MIAMI, Nov. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nine months ended September 30, 2024. Highlights from...